Compare MRBK & CNTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MRBK | CNTN |
|---|---|---|
| Founded | 2004 | 2017 |
| Country | United States | United States |
| Employees | N/A | 3 |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 222.3M | 184.2M |
| IPO Year | 2018 | 2022 |
| Metric | MRBK | CNTN |
|---|---|---|
| Price | $18.95 | $3.26 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $20.00 | N/A |
| AVG Volume (30 Days) | 72.6K | ★ 462.2K |
| Earning Date | 04-24-2026 | 05-11-2026 |
| Dividend Yield | ★ 2.97% | N/A |
| EPS Growth | ★ 30.34 | N/A |
| EPS | ★ 1.89 | N/A |
| Revenue | ★ $6,316,000.00 | N/A |
| Revenue This Year | $25.40 | N/A |
| Revenue Next Year | $8.15 | N/A |
| P/E Ratio | $9.98 | ★ N/A |
| Revenue Growth | ★ 10.13 | N/A |
| 52 Week Low | $11.17 | $3.07 |
| 52 Week High | $21.03 | $5.27 |
| Indicator | MRBK | CNTN |
|---|---|---|
| Relative Strength Index (RSI) | 49.83 | 33.46 |
| Support Level | $18.10 | $3.15 |
| Resistance Level | $19.53 | $3.51 |
| Average True Range (ATR) | 0.64 | 0.31 |
| MACD | 0.02 | -0.04 |
| Stochastic Oscillator | 52.48 | 14.44 |
Meridian Corp is a bank holding company based in the United States. Through its banking subsidiary, it operates as a full-service, state-chartered commercial bank providing personal and business lending and deposit services. It operates in three reportable segments, including Bank, Wealth, and Mortgage. Meridian generates maximum revenue from the Bank segment, which consists of commercial and retail banking. It generates interest income from its lending (including leasing) and investing activities and is dependent on the gathering of lower-cost deposits from its branch network or borrowed funds from other sources for funding its loans. Geographically, it operates in Pennsylvania, New Jersey, and Delaware, as well as in the Central Maryland market and southwest Florida, U.S.
Canton Strategic Holdings Inc is engaged in activities related to Canton Network, including the use of Canton Coin, to support blockchain-based infrastructure and the digitization of financial market processes. The company also operates a validator node on the Canton Network to facilitate transaction validation and network operations. It also operates a clinical-stage biotech research and development arm. Its flagship clinical asset, GV104, is being developed for a specific indication for respiratory and/or nervous system depression in military personnel and chemical incident responders. The expanded pipeline includes other indications for GV104 and GV023, an approach to autoimmune diseases as well as an early-stage multispecific biologic platform.